PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes.

Saved in:
Bibliographic Details
Title: PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes.
Authors: Hastie E; University of California San Diego, San Diego, California, USA., Srivasta M; University of California San Diego, San Diego, California, USA., Cachay ER; Mayo Clinic, Rochester, Minnesota, USA., Burke L; University of California San Diego, San Diego, California, USA., Gianella S; University of California San Diego, San Diego, California, USA., Rawlings S; Maine Medical Center, Portland, Maine, USA., Stanczyk FZ; University of Southern California, Los Angeles, California, USA., Sykes C; University of North Carolina, Chapel Hill, North Carolina, USA., Kashuba ADM; University of North Carolina, Chapel Hill, North Carolina, USA., Blumenthal J; University of California San Diego, San Diego, California, USA., Cottrell ML; University of North Carolina, Chapel Hill, North Carolina, USA.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2026 May 07. Date of Electronic Publication: 2026 May 07.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2125
DOI:10.1002/bcp.70586